ClinicalTrials.Veeva

Menu

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Enrolling

Conditions

Low Risk
Radiofrequency Ablation
Papillary Thyroid Cancer

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT07140757
2025-0083
NCI-2025-06179 (Other Identifier)

Details and patient eligibility

About

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Full description

Primary Objectives

• To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care

Secondary Objectives

  • To establish the health-related quality of life among participants undergoing with ultrasound guided RFA.
  • To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA.
  • To assess adverse events rates following ultrasound guided RFA.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria

  1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC

  2. Participant is over 18 years and is either not a surgical candidate or has declined surgery.

  3. Capable and willing to provide written informed consent

  4. Participant has one of the following diagnoses:

    • Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
    • Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
    • Papillary thyroid carcinoma (PTC) without metastasis
    • Locally recurrent thyroid cancer (< 2 cm).

Exclusion Criteria

  1. Participants meeting any of the following criteria will be excluded:
  2. Participants considered unsuitable for RFA by the treating physician

Trial contacts and locations

1

Loading...

Central trial contact

Victoria E Banuchi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems